Ligand Pharmaceuticals LGND Income Statements

Conto economico

Quarter End	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	66,09M	27,05M	43,98M	26,37M	34,99M	28,1M	30,98M	41,53M
Reddito operativo	636k	12,18M	14,21M	-1,98M	3,08M	-3,36M	2,99M	-19,1M
Reddito ante imposte	857k	55,93M	55,54M	3,17M	-12,14M	17,1M	113,45M	-65,39M
Reddito netto	404k	-17,49M	41,95M	2,29M	-10,27M	18,19M	86,14M	-51,91M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,52M	10,9M	14,81M	-2,86M	-1,22M	1,38M	600k	-48,33M
EBITDA	13,92M	9,81M	23,7M	24,59M	-4,47M	4,63M	11,75M	16,24M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	108,97M	141,1M	251,45M	120,28M	186,42M	314,73M	196,25M	131,31M
Reddito operativo	40,55M	66,03M	213,91M	-5,72M	8,73M	78,9M	3,04M	9,82M
Reddito ante imposte	7,96M	57,23M	173,33M	796,64M	-10,54M	47,3M	36,01M	63,66M
Reddito netto	-1,64M	12,56M	143,32M	629,3M	-2,99M	57,14M	-33,36M	52,15M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.078	0.594	6.902	37.407	-0.186	3.408	-1.968	2.991
UTILE OPERATIVO	20,14M	68,63M	207,61M	801,07M	25,74M	70,04M	7,22M	9,99M
EBITDA	51,39M	78,55M	230,61M	38,01M	36,25M	129,96M	41,07M	46,34M